CompletedPhase 4

Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure

Italy100 participantsStarted 2012-12

Plain-language summary

The purpose of this study is to determine whether in Assisted Reproductive Technologies the use of culture medium supplemented with GM-CSF, a growth factor working on stem cells, may improve the embryo implantation in patients experiencing recurrent implantation failure in IVF cycles.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * woman age 40 years old or less, * 3 or more consecutive previous failed IVF cycles with a total of at least 8 good embryos replaced in uterus Exclusion Criteria: * chromosomal defects in the couple, * metabolic diseases (diabetes, etc), * other genetic diseases (thalassemia, cystic fibrosis, etc.)

What they're measuring

Pregnancy rate

Timeframe: 9 months

Trial details

NCT IDNCT01718210

SponsorCentre for Endocrinology and Reproductive Medicine, Italy

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Infertility trials